Evidence map›Paper›PMID 36638209›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Urokinase plasminogen activator surface receptor restricts HIV-1 replication by blocking virion release from the cell membrane.

Hailin Pang, Jiayue Ouyang, Zengwen Yang, Hong Shang, Guoxin Liang

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hailin PangKey Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.ORCID 0000-0003-2828-0510
Jiayue OuyangKey Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
Zengwen YangKey Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
Hong ShangKey Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.
Guoxin LiangKey Laboratory of Acquired Immune Deficiency Syndrome (AIDS) Immunology of Ministry of Health, Department of Laboratory Medicine, The First Hospital of China Medical University, Shenyang 110122, China.ORCID 0000-0003-1789-9094
First Hospital of China Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The urokinase-type plasminogen activator (uPA) system consists of the proteinase uPA, its receptor (PLAUR/uPAR). Under physiological conditions, uPA and PLAUR are predominantly expressed by blood cells, including neutrophils, monocytes, and macrophages, and play important roles in cell activation, adhesion, migration, and extravasation. Here, we report that PLAUR, which is highly expressed in macrophages and dendritic cells (DCs) but hardly expressed in CD4

Indexed as

HIV-1Receptors, Urokinase Plasminogen ActivatorVirus ReplicationCell MembraneHumansUrokinase-Type Plasminogen ActivatorVirionPLAUR protein, humanReceptors, Urokinase Plasminogen ActivatorUrokinase-Type Plasminogen ActivatorHIV-1PLAURuPA

Identifiers

PMID36638209
PMCPMC9934069
OpenAlexW4316015790

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.